Kura Oncology (KURA) Priced

Developing in-licensed protein inhibitors for solid tumors and blood cancers.

Health Care - Biotechnology

IPO Performance
Latest Trade $7.60 0.00 (0.0%)
First Day Return -2.0%
Return from IPO -5.0%
 
Kura Oncology IPO News more
  • .
IPO Data
IPO File Date 10/20/2015
Offer Price $8.00
Price Range $8.00 - $8.00
Offer Shares (mm) 6.3
Deal Size ($mm) 50
 
IPO Data
IPO Date 11/04/2015
Offer Price $8.00
Price Range $8.00 - $8.00
Offer Shares (mm) 6.3
Deal Size ($mm) $50
 
Underwriters
more
Business Overview
Developing in-licensed protein inhibitors for solid tumors and blood cancers.
Developing in-licensed protein inhibitors for solid tumors and blood cancers.
more
Company Data
Headquarters La Jolla, CA
Founded 2014
Employees 21
Website www.kuraoncology.com
 

Performance vs. IPO Index (IPOUSA)